Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Jim C. Hu, M.D.

Jim C. Hu, M.D.

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

Jim Hu, M.D. ~ Sharp drop in prostate cancer procedures after PSA screening curb (MDalert.com)

By David Douglas

NEW YORK (Reuters Health) - Since guidelines recommended a halt to population-based prostate specific antigen (PSA) screening, there has been a significant drop in the volume of prostate biopsy and radical prostatectomy, according to researchers.

The U.S. Preventive Services Task Force (USPSTF) recommended against routine PSA screening in 2012.

(MedScape with Dr. Hu) Big Drop in Prostate Biopsies, Prostatectomies in US

This is an excerpt from Medscape, featuring Dr. Jim Hu. Read the full text here.

Since the US Preventive Services Task Force (USPSTF) issued its recommendation against prostate-specific antigen (PSA) screening in 2012, the use of PSA screening and digital rectal examinations has decreased significantly, as has the incidence of early-stage prostate cancer.

(NBC News with Dr. Hu) Prostate Surgery Rates Fall After Screening Advice, Study Finds

Significant decrease seen in prostate biopsy, radical prostatectomy procedures following recommendations

In a study published online by JAMA Surgery, Jim C. Hu, M.D., M.P.H., Joshua A. Halpern, M.D., M.S., of Weill Cornell Medicine, New York, and colleagues examined effects on practice patterns in prostate cancer diagnosis and treatment following the U.S. Preventative Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA) screening in 2012.

Significant decrease seen in prostate biopsy, radical prostatectomy procedures following recommendations

In a study published online by JAMA Surgery, Jim C. Hu, M.D., M.P.H., Joshua A. Halpern, M.D., M.S., of Weill Cornell Medicine, New York, and colleagues examined effects on practice patterns in prostate cancer diagnosis and treatment following the U.S. Preventative Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA) screening in 2012.

What does the future hold for robotics in medicine? (92Y Panel with Weill Cornell Medicine)

What does the future hold for robotics in medicine?

Medical experts from Weill Cornell Medicine discuss this fascinating topic. Joining us for this panel are Cheguevara Afaneh, MD; T. Sloane Guy, MD; Jim Hu, MD; Jeffrey Port, MD; Douglas Scherr, MD; and Joel Stein, MD, with moderator Dr. Max Gomez from WCBS-TV.

The past decade has produced tremendous advances in the use of robotics across clinical areas, vastly expanding the horizons of disease management.

Pages

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.